EternaTear, Inc.
Synthetic tear film or topical therapeutic for dry eye disease
- Sector
- Medtech
- Headquarters
- RALEIGH, NC
- Founded
- 2018
- Latest Form D
- $2.2M, Apr 2020
- Total capital
- $2.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2.2M
- 1 Form D · last Apr 2020
- 79 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 4 pending · first 2022
- Rank in peer group#3 of 29
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$2.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 29 peers
Line = medianMedtech · Molecule
- Granted patents#3 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Timothy WillisResearcherExecutive Officer, DirectorLinked by 4 patents
- Diethart ReichardtExecutive Officer, DirectorNamed in SEC Form D filings
- Kent GeerExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 9- PendingOphthalmic Formulations And Related MethodsUSPTOApplication 18731562
- GrantedOphthalmic Formulations And Related MethodsUSPTOUS 12,005,139
- GrantedOphthalmic Formulations And Related MethodsUSPTOUS 11,964,047
Show all 9 patent records
- Ophthalmic Formulations And Related MethodsSep 26, 2024 · Application 18731562Pending
- Ophthalmic Formulations And Related MethodsJun 11, 2024 · US 12,005,139Granted
- Ophthalmic Formulations And Related MethodsApr 23, 2024 · US 11,964,047Granted
- Ophthalmic Formulations And Related MethodsJun 20, 2023 · US 11,679,079Granted
- Ophthalmic Formulations And Related MethodsJun 20, 2023 · US 11,679,078Granted
- Ophthalmic Formulations Providing Durable Ocular LubricationMar 22, 2022 · US 11,278,493Granted
- Ophthalmic Formulations Providing Durable Ocular LubricationDec 16, 2021 · Application 17400298Pending
- Ophthalmic Formulations Providing Durable Ocular LubricationApplication PCTUS2019065191Pending
- Ophthalmic Formulations And Related MethodsApplication PCTUS2023014590Pending
Related companies, and why
- Native Cardio, Inc.Similar federal contract value in Medtech · null in contracts
- Valar Labs, Inc.Similar federal contract value in Medtech · null in contracts
- PELVA HEALTH CORPORATIONSimilar federal contract value in Medtech · null in contracts
- PathRight Medical Inc.Similar federal contract value in Medtech · null in contracts
- Prana Thoracic, Inc.Similar federal contract value in Medtech · null in contracts
- Navigation Sciences, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .